Several industries have an increasing interest in improving their access to pure single enantiomers of biologically active substances. The latter often form the basis for valued added products relevant for, among others, the pharmaceutical, cosmetic, and food industries. Up to now there exist two generally rivalling concepts for producing pure enantiomers. One approach is based on developing and a ...